DOD FY12 Neurofibromatosis Clinical Trial Award | Apply Online

Opportunity Summary:

The DOD FY12 Neurofibromatosis Clinical Trial Award (Funding Opportunity Number W81XWH 12 NFRP CTA) was a U.S. Department of Defense Neurofibromatosis Research Program funding opportunity administered through the Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA). It was designed specifically to move neurofibromatosis (NF) research into patient-focused testing by supporting clinical trials that could meaningfully improve how NF is treated or managed. The intent of the mechanism was translational and impact-driven: applicants were expected to propose studies that could change clinical practice or substantially advance the evidence base for NF care, rather than exploratory laboratory work.

The award mechanism supported pilot trials as well as Phase 0, Phase I, or Phase II clinical trials. In practical terms, that scope covers early human studies that examine things like feasibility, safety, dosing, pharmacokinetics/pharmacodynamics, initial signals of efficacy, and early-stage comparative outcomes depending on the design. A key restriction was that funds had to be used to conduct a clinical trial; the announcement explicitly stated that the award could not be used for preclinical research studies. That makes this opportunity distinct from many biomedical grants that allow a mix of lab, animal, and human work. Here, the expectation was that the project would be trial-ready and focused on activities directly tied to executing the clinical study in humans.

From an administrative standpoint, the opportunity fell under the “Discretionary” category and supported awards through a Cooperative Agreement and/or Grant instrument type, within the Science and Technology / Research and Development activity area. The CFDA listing associated with the program was 12.420 (Military Medical Research and Development). The program anticipated making about two awards, with an estimated total funding amount of $2,880,000 across all awards. There was no cost sharing or matching requirement stated, meaning applicants were not required to contribute non-federal funds as a condition of receiving the award.

Eligibility was described as “Unrestricted,” indicating it was broadly open to any type of entity, subject to any additional eligibility clarifications that would have appeared in the full text of the announcement. The posting date and creation date were both March 22, 2012. The original and current closing date were May 31, 2012, and the opportunity was later archived on June 30, 2012. For applicant support, the announcement directed anyone having trouble accessing the full announcement to contact the CDMRP help resources (PA HELP and eReceipt HELP) via phone at 301-682-5507 or email at help@cdmrp.org.

Overall, this grant opportunity can be summarized as an early-phase NF clinical trial funding mechanism from the DoD intended to accelerate tangible patient impact by paying for the execution of pilot through Phase II clinical trials, while explicitly excluding preclinical research from allowable use of funds.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: DOD FY12 Tuberous Sclerosis Complex Exploration Hypothesis Development Award

Previous opportunity: BLM WY Mycological Resources Inventory CESU

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 12 NFRP CTA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 12 NFRP CTA) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 12 NFRP CTA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.